ema prac naion semaglutide medicines such as Ozempic, Wegovy, and Rybelsus have been reviewed by UK and EU regulators in relation to a rare optic nerve condition called NAION. Swipe through for the key red EMA's PRAC starts semaglutide review

Long-term effects of semaglutide on gastrointestinal safety and tolerability: A post-hoc analysis of the SUSTAIN trials

For semaglutide, the half-life is 6 to 7 days, which is about a week

Exposure to xenobiotics, heavy metals (such as lead, mercury and arsenic), stress, poor dietary choices, toxic cocktails of prescription and non-prescription drugs, trauma and infections all have huge consequences for the body and its ability to maintain adequate glutathione levels

Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation

If medication is not necessary for your journey or you are not eligible for medication, we suggest taking a look at our Non-Medical Program